Sex and cardiovascular disease status differences in attitudes and willingness to participate in clinical research studies/clinical trials

[1] Mosca L(2010)Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health Circ Cardiovasc Qual Outcomes. 3 120-127

[2] Mochari-Greenberger H(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321-333

[3] Dolor RJ(2002)Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina J Am Coll Cardiol 39 231-237

[4] Newby LK(2005)A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 1293-1304

[5] Robb KJ(2014)Representation of women in randomized clinical trials of cardiovascular disease prevention Curr Cardiovasc Risk Rep 8 1-5

[6] Rossouw JE(2011)Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association Circulation 123 1243-1262

[7] Anderson GL(2007)Who refuses enrollment in cardiac clinical trials? Clin Trials 4 258-263

[8] Prentice RL(2008)Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion J Am Coll Cardiol 52 672-673

[9] LaCroix AZ(2010)Representation of women in randomized clinical trials of cardiovascular disease prevention Circ Cardiovasc Qual Outcomes 3 135-142

[10] Kooperberg C(2013)Patient- and trial-specific barriers to participation in cardiovascular randomized clinical trials J Am Coll Cardiol 61 762-769

[1] Mosca L(2010)Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health Circ Cardiovasc Qual Outcomes. 3 120-127

[2] Mochari-Greenberger H(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321-333

[3] Dolor RJ(2002)Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina J Am Coll Cardiol 39 231-237

[4] Newby LK(2005)A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 1293-1304

[5] Robb KJ(2014)Representation of women in randomized clinical trials of cardiovascular disease prevention Curr Cardiovasc Risk Rep 8 1-5

[6] Rossouw JE(2011)Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association Circulation 123 1243-1262

[7] Anderson GL(2007)Who refuses enrollment in cardiac clinical trials? Clin Trials 4 258-263

[8] Prentice RL(2008)Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion J Am Coll Cardiol 52 672-673

[9] LaCroix AZ(2010)Representation of women in randomized clinical trials of cardiovascular disease prevention Circ Cardiovasc Qual Outcomes 3 135-142

[10] Kooperberg C(2013)Patient- and trial-specific barriers to participation in cardiovascular randomized clinical trials J Am Coll Cardiol 61 762-769